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Biological Research Center, Szeged, Hungary.The efﬁciency of canonical serine protease inhibitors is conventionally attributed to the rigidity of
their protease binding loop with no conformational change upon enzyme binding, yielding an
example of the lock-and-key model for biomolecular interactions. However, solution-state struc-
tural studies revealed considerable ﬂexibility in their protease binding loop. We resolve this appar-
ent contradiction by showing that enzyme binding of small, 35-residue inhibitors is actually a
dynamic conformer selection process on the nanosecond-timescale. Thus, fast timescale dynamics
enables the association rate to be solely diffusion-controlled just like in the rigid-body model.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Canonical, standard mechanism serine protease inhibitors
belong to several evolutionarily unrelated families, yet possess a
structurally similar segment, the protease binding loop, mainly
responsible for their interaction with the target enzyme. This loop
binds into the substrate binding cleft of the cognate protease(s)
and is even cleaved in a substrate-like manner, albeit with a low
rate and an equilibrium constant near unity [1]. Canonical
inhibitors are traditionally viewed as classical examples of the
‘lock-and-key’ inhibitory mechanism, in which the free inhibitor
is fairly rigid and structural changes are restricted upon complex-
ation [2–4]. This view is based on the observation that X-ray
structures of several free and complexed inhibitors show little
structural differences in their protease binding loop, as measured
by the deviation of backbone dihedral angles [3]. However,
heteronuclear NMR studies have revealed that the interaction site
of canonical protease inhibitors in complex with the enzyme ischemical Societies. Published by E
istry and Biology Laboratory,
mány Péter sétány 1/A, 1117
up, Institute of Biochemistry,ﬂexible on the ps–ns timescale [5–9]. These observations are in
line with recent experimental and theoretical results emphasizing
the role of internal dynamics in protein function in general [10–12]
and are in apparent contradiction with the rigid lock-and-key
model widely accepted for canonical serine protease inhibitors.
To assess the role of ps–ns timescale dynamics in canonical ser-
ine protease inhibition, we performed dynamically restrained
molecular simulations on small, 35-residue inhibitors that exhibit
picomolar inhibition of their target enzymes. These highly potent
inhibitors are therefore ideal models to study the role of internal
ﬂexibility in protein binding. Interestingly, generalized order
parameters (S2 values) derived from NMR spectroscopy data indi-
cate low motional restriction of backbone N–H moieties in the
range of 0.6–0.7 throughout the backbone, not just in their primary
protease binding region (0 corresponds to totally unrestricted,
while 1 to restricted motion) [13]. Similar values are characteristic
of interaction sites in proteins, including the enzyme binding
regions of larger, unrelated canonical inhibitors. One of the
inhibitors studied here, SGCI (Schistocerca gregaria chymotrypsin
inhibitor), has shown overall changes upon binding to its target
enzyme as followed by NMR spectroscopy, indicating that residues
far from the primary contact site are inﬂuenced by complex forma-
tion [14]. Another inhibitor, SGTI ( S. gregaria trypsin inhibitor)
possesses an extended enzyme binding site adjacent to the strictly
deﬁned protease binding loop [15]. A recent phage-display studylsevier B.V. All rights reserved.
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enzyme selectivity of SGTI variants [16]. Thus, these inhibitors can
be regarded as ‘whole-molecule binding loops’, globally inﬂuenced
by the interaction with the enzyme, rendering the recognition and
analysis of the role of internal dynamics easier compared to sys-
tems where only limited local changes occur.
2. Methods
Dynamically restrained molecular dynamics simulations were
performed in GROMACS [17] as described previously [18,19].
Brieﬂy, eight replicas of the inhibitors were simulated in parallel
in explicit water. The simulations were restrained to reproduce
the generalized order parameters ðS2Þ, calculated across all replicas
at each simulation step, and the NOE distance restraints that were
treated in a pairwise manner. Four 230 ps long simulated anneal-
ing cycles yielded 32 ﬁnal structures in the dynamic ensembles.
Principal component analysis was done with the PCA_NEST [20]
server, neighbor-joining analysis on different metrics with the
PHYLIP package and all other analyses with in-house programs.
Detailed description of the methods can be found in the Supple-
mentary data.
3. Results and discussion
We have generated dynamically restrained ensembles of SGCI
and SGTI by the MUMO (minimal under-restraining minimal
over-restraining) protocol [18,19] using NOE [21] and backbone
N–H S2 data [13]. The structural diversity in the resulting ensemble
primarily stems from the internal dynamics of the inhibitor on the
ps–ns timescale. These dynamic structural ensembles exhibit
excellent agreement with experimental data including chemical
shifts that were used as independent measures for cross-correla-
tion analysis (Fig. 1). In fact, correlation of back-calculated Ha
shifts and experimental data improved considerably, compared
with the structures determined using ‘conventional’ single-con-
former NOE reﬁnement (referred to as SCR) protocol (Fig. S1).
The structural ensembles of SGCI and SGTI determined by the
MUMO protocol show considerable heterogeneity in accord with
the low experimental S2 values, mapping a remarkably larger con-
formational space than their SCR counterparts (Fig. 2). Neverthe-
less, variations in the structures do not adversely affect theFig. 1. Dynamic ensembles of inhibitors SGCI and SGTI. Left: superimposed structures
correlation of calculated N–H S2 order parameters and back-calculated Ha chemical shirecalculation of S2 values by procedures considering the anisotropy
of N–H vector distributions [22], suggesting the robustness of the
computational procedure even for such ﬂexible molecules
(Fig. S2). Moreover, our detailed analysis of selected sidechain–
sidechain interactions in the two molecules show that the dynamic
ensembles are not simply overly relaxed conformer sets with a uni-
formly high RMSD. Residues considered pivotal in structure stabil-
ization, the Phe10-Ala26 pair in SGCI and the Lys10-Trp25 pair in
SGTI [23] are, on average, more restricted in the dynamic ensem-
bles compared with structures obtained by SCR (Fig. 2).
To assess the role of ps–ns timescale dynamics in protease bind-
ing, we compared the MUMO ensembles of SGCI and SGTI with
available X-ray structures of their enzyme-bound counterparts
[15] (for SGCI, the chymotrypsin-bound structure of one of its close
homologues is used [24]). Neighbor-joining analysis using pairwise
conformer distances based on both RMSD data and backbone dihe-
dral angle (u and w) differences show that complexed inhibitors
cluster within the conformational space of the dynamic structures
(Figs. S3 and S4). Principal component analysis [20] strongly sup-
ports the observation that backbone conformations present in
the bound state are also accessible in solution. In contrast, struc-
tures of the same inhibitors determined by using the SCR protocol
represent a conformer set distinctly different from the complexed
states (Fig. 3). We note that the present analysis of backbone mo-
tions is robust since solely the backbone is restrained by both NOE
and S2 data in the simulations.
Analysis of the distributions of backbone dihedral angles in the
protease binding loop region of SGCI and SGTI shows that dynamic
structures sample regions of the conformational space also adopted
in the bound state. On the other hand, many of the u and w angles
are not constrained to the ‘canonical values’, derived from the anal-
ysis of static X-ray structures of free and enzyme-bound inhibitors
[4] which forms the basis of the rigid-body-interaction hypothesis.
Therefore, we propose that conformational changes inevitably
occur upon enzyme binding, in contrast to the lock-and-key
mechanism. Solution-state NMR and computational studies on a
variety of unrelated canonical inhibitors corroborate this ﬁnding
[5–9,25].
Picosecond-to-nanosecond timescale dynamics, deciphered
from backbone S2 values, is faster than molecular rotation and
intermolecular association rates and thus has not generally been
considered to play signiﬁcant roles in molecular recognition ofwith the protease binding loop darkened and the N- and C-termini labeled. Right:
fts with experimental data.
Fig. 2. Heterogeneity of the dynamic and SCR inhibitor ensembles. From left to right: structural ensembles mapped to the ﬁrst two largest PCA modes (calculated on the
combined SCR and dynamic ensembles); backbone RMSD values (with respect to the mean structure) of the ensembles calculated for residues in the protease binding loop
(residues 28–33 for SGCI and 27–32 for SGTI) and the scaffold of the molecule (residues 4–27 for SGCI and 4–26 for SGTI); heavy atom RMSD of the core-forming residues
calculated separately for the different ensembles; schematic representation of the inhibitor structure with the b-strands, disulﬁde bridges, protease binding loop and core
interaction site indicated.
Fig. 3. Comparison of the dynamic and SCR ensembles with the bound-state conformations of the inhibitors. Top: structural superpositions of the dynamic ensembles with
the complexed structures are shown along with the ﬁrst two largest PCA modes for the combined dynamic + complexed and SCR + complexed ensembles. Bottom: backbone
dihedral angles of the binding loop in the dynamic ensembles and the complexed structures are shown along with their ‘canonical ranges’ [4].
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are generally small-amplitude local ﬂuctuations, in contrast to lar-
ger-amplitude rearrangements on slower timescales (from ls to
ms) typically associated with biological function [26]. Our study
reveals the presence of enzyme-bound conformers in the structural
ensemble of the free inhibitors in solution which is also consistent
with earlier predictions of the rigid-body model. In either case,
conformational motions do not adversely affect the association
rate with proteases, measured to be in the order of 106 M1 s1
for the (unrelated) canonical inhibitor eglin c [27]. Interconversion
from a non-productive conformation to an active one takes place
faster than interaction with the partner protease since no signiﬁ-
cant energetic cost is required for conformational rearrangements
in an equilibrium ensemble. However, in contrast to the rigid bind-
ing loop model, different conformational states may be selected by
different enzymes from the dynamic pool of inhibitor structures in
solution [28]. Our results support an equilibrium shift model of the
inhibitors upon enzyme binding, which also explains the large
chemical shift changes observed for SGCI during its interaction
with chymotrypsin. Motional restriction is expected to result in en-
tropy loss for the inhibitor in action (for a pictorial representation
see Fig. S5). A recent computational study [25] including an unre-
lated canonical inhibitor is in line with this expectation but with
the notable result of a net entropy gain for the whole complex
formed with protease. It should be noted that supra-ns dynamics
of the free and complexed states [14,29], together with site-spe-
ciﬁc interactions [3] and factors governing the dissociation rate
of the enzyme-inhibitor complex all contribute to the observed
high efﬁciency of canonical serine protease inhibitors.
Nanosecond-timescale conformational selection may well be a
general phenomenon, as relatively low S2 order parameter values
indicate the presence of considerable motions of interaction sites
in a number of proteins. This also suggests that fast internal mo-
tions should also be considered to account for the full details of
ﬁne-tuned biomolecular interactions and exploited in inhibitor de-
sign. Alas, neither the locks nor the keys are actually rigid as envi-
sioned by the early pioneers of structural biology [30].
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